Taking together, leptin replacement therapy could be therapeutic opportunities not only for obesity and diabetes, but also for obesity-related depression and anxiety (Johnston et al., 2011). This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.